Expression of mHTT has been shown to increase p53 target gene expression, whereas deleting p53 in the HD transgenic mouse brain rescues the behavioral abnormalities (Bae et al., 2005) highlighting the fact that mHTT-mediated chronic activation of DDR-p53 pathway contributes to neurotoxicity in HD. The gene discussed is TP53; the disease is Huntington disease.